John Fung to Aged
This is a "connection" page, showing publications John Fung has written about Aged.
Connection Strength
0.838
-
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol. 2012 May; 10(5):540-6.
Score: 0.030
-
Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant. 2010 Dec; 10(12):2665-72.
Score: 0.027
-
Robotic versus laparoscopic resection of liver tumours. HPB (Oxford). 2010 Oct; 12(8):583-6.
Score: 0.027
-
Side-to-side cavocavostomy with an endovascular stapler: Rescue technique for severe hepatic vein and/or inferior vena cava outflow obstruction after liver transplantation using the piggyback technique. Liver Transpl. 2009 Jan; 15(1):49-53.
Score: 0.024
-
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl. 2005 Nov; 11(11):1425-30.
Score: 0.019
-
Long-term outcome of adding mycophenolate mofetil to tacrolimus for nephrotoxicity following liver transplantation. Transplantation. 2005 Sep 27; 80(6):859-64.
Score: 0.019
-
Tobacco use following liver transplantation for alcoholic liver disease: an underestimated problem. Liver Transpl. 2005 Jun; 11(6):679-83.
Score: 0.019
-
[Analysis of causes of late mortality in liver transplant recipients]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004 Sep; 16(9):547-51.
Score: 0.018
-
Outcomes in 139 cases of biliary tract reconstructions from a transplant surgery center. Exp Clin Transplant. 2003 Dec; 1(2):73-8.
Score: 0.017
-
Conversion from tacrolimus to cyclosporine--a based immunosuppression following liver transplantation. Exp Clin Transplant. 2003 Jun; 1(1):48-55.
Score: 0.016
-
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl. 2003 Mar; 9(3):239-47.
Score: 0.016
-
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl. 2002 Jan; 8(1):40-6.
Score: 0.015
-
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. J Clin Pharmacol. 2001 Mar; 41(3):268-76.
Score: 0.014
-
Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transpl. 2000 Jul; 6(4):434-9.
Score: 0.013
-
Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. Transplant Proc. 2000 May; 32(3):663-4.
Score: 0.013
-
Simultaneous heart, liver and kidney transplantation: A viable option for heart failure patients with multiorgan failure. J Heart Lung Transplant. 2019 09; 38(9):997-999.
Score: 0.012
-
Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. J Transpl Coord. 1999 Jun; 9(2):101-3.
Score: 0.012
-
Renal transplantation in recipients over the age of 60: the impact of donor age. Transplantation. 1999 Apr 27; 67(8):1191-3.
Score: 0.012
-
Minimally invasive resection of posterosuperior liver tumors in the supine position using intra-abdominal trocars. Surg Endosc. 2020 02; 34(2):536-543.
Score: 0.012
-
Primary adult liver transplantation under tacrolimus: more than 90 months actual follow-up survival and adverse events. Liver Transpl Surg. 1999 Mar; 5(2):144-50.
Score: 0.012
-
Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc. 1998 Jun; 30(4):1403-4.
Score: 0.011
-
A new technique for hepatic parenchymal transection using an articulating bipolar 5 cm radiofrequency device: results from the first 100 procedures. HPB (Oxford). 2018 09; 20(9):829-833.
Score: 0.011
-
Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. Liver Transpl. 2018 02; 24(2):233-245.
Score: 0.011
-
Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. Surgery. 2017 09; 162(3):525-536.
Score: 0.011
-
Liver transplantation in patients with incidental hepatocellular carcinoma/cholangiocarcinoma and intrahepatic cholangiocarcinoma: a single-center experience. Hepatobiliary Pancreat Dis Int. 2017 Jun; 16(3):264-270.
Score: 0.011
-
Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis. Lancet Gastroenterol Hepatol. 2017 08; 2(8):595-603.
Score: 0.011
-
"Pants" vein jump graft for portal vein and superior mesenteric vein thrombosis in transplantation of the liver. J Am Coll Surg. 1996 Nov; 183(5):527-8.
Score: 0.010
-
Perioperative and oncologic outcomes of minimally invasive liver resection for colorectal metastases: A case-control study of 130 patients. Surgery. 2016 10; 160(4):1097-1103.
Score: 0.010
-
Role of Doppler Sonography in Early Detection of Splenic Steal Syndrome. J Ultrasound Med. 2016 Jul; 35(7):1393-400.
Score: 0.010
-
Transjugular intrahepatic portosystemic shunt in patients with end-stage liver disease: results in 85 patients. Liver Transpl Surg. 1996 Mar; 2(2):139-47.
Score: 0.010
-
Presence of retinal pericyte-reactive autoantibodies in diabetic retinopathy patients. Sci Rep. 2016 Feb 03; 6:20341.
Score: 0.010
-
Safety and Efficacy of a New Bipolar Energy Device for Parenchymal Dissection in Laparoscopic Liver Resection. Surg Laparosc Endosc Percutan Tech. 2016 Feb; 26(1):21-4.
Score: 0.010
-
Oncologic results of laparoscopic liver resection for malignant liver tumors. J Surg Oncol. 2016 Feb; 113(2):127-9.
Score: 0.010
-
Hepatic artery angioplasty after liver transplantation: experience in 21 allografts. J Vasc Interv Radiol. 1995 Jul-Aug; 6(4):523-9.
Score: 0.009
-
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study. Transplantation. 2015 Jul; 99(7):1455-62.
Score: 0.009
-
Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation. Liver Transpl. 2015 Jan; 21(1):101-11.
Score: 0.009
-
Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol. 2014 Jun; 29(6):1250-7.
Score: 0.009
-
Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity. 1994; 19(2):89-98.
Score: 0.008
-
Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies. Transpl Immunol. 1994; 2(1):61-7.
Score: 0.008
-
Efficacy of laparoscopic radiofrequency ablation for the treatment of patients with small solitary colorectal liver metastasis. Surgery. 2013 Sep; 154(3):556-62.
Score: 0.008
-
Radiologic-histological correlation of hepatocellular carcinoma treated via pre-liver transplant locoregional therapies. Hepatobiliary Pancreat Dis Int. 2013 Feb; 12(1):34-41.
Score: 0.008
-
Multicentre results of stereotactic body radiotherapy for secondary liver tumours. HPB (Oxford). 2013 Nov; 15(11):851-7.
Score: 0.008
-
Laparoscopic versus open resection of colorectal liver metastasis. Surg Endosc. 2013 Apr; 27(4):1138-43.
Score: 0.008
-
A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology. 1992 Sep; 16(3):671-81.
Score: 0.008
-
Predicting the discharge status after liver transplantation at a single center: a new approach for a new era. Liver Transpl. 2012 Jul; 18(7):796-802.
Score: 0.008
-
Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. HPB (Oxford). 2012 May; 14(5):325-32.
Score: 0.007
-
Multicenter results of stereotactic body radiotherapy (SBRT) for non-resectable primary liver tumors. Acta Oncol. 2012 May; 51(5):575-83.
Score: 0.007
-
Patient participation in research among solid organ transplant recipients in the United States. Transplantation. 2011 Jun 27; 91(12):1424-35.
Score: 0.007
-
Combined liver-kidney transplants: allosensitization and recipient outcomes. Transplantation. 2011 Jun 15; 91(11):1286-92.
Score: 0.007
-
Techniques of radiofrequency-assisted precoagulation in laparoscopic liver resection. Surg Endosc. 2011 Apr; 25(4):1143-7.
Score: 0.007
-
Liver transplantation at Cleveland Clinic. Clin Transpl. 2010; 195-206.
Score: 0.006
-
Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006 Aug; 30(8):986-93.
Score: 0.005
-
Expanding the donor pool: safe transplantation of a cadaveric liver allograft with a 10 cm cavernous hemangioma--a case report. Liver Transpl. 2006 Apr; 12(4):687-9.
Score: 0.005
-
Effect of age and postoperative time on cytochrome p450 enzyme activity following liver transplantation. J Clin Pharmacol. 2005 Jun; 45(6):666-73.
Score: 0.005
-
Preliminary report on surgical technique in hepatic parenchymal transection for liver tumors in the elderly: a lesson learned from living-related liver transplantation. J Surg Oncol. 2004 Dec 15; 88(4):229-33.
Score: 0.005
-
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation. 2004 Oct 15; 78(7):966-71.
Score: 0.004
-
Synergistic effect of cold and warm ischemia time on postoperative graft outcome in human liver transplantation. Hepatogastroenterology. 2004 Sep-Oct; 51(59):1413-6.
Score: 0.004
-
Synergistic effect of cold and warm ischemia time on postoperative graft function and outcome in human liver transplantation. Transplant Proc. 2004 Sep; 36(7):1955-8.
Score: 0.004
-
Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol. 2004 May; 28(5):658-69.
Score: 0.004
-
Clostridium difficile colitis in patients after kidney and pancreas-kidney transplantation. Transpl Infect Dis. 2004 Mar; 6(1):10-4.
Score: 0.004
-
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg. 2003 Oct; 238(4):520-5; discussion 525-7.
Score: 0.004
-
Minimal evidence of transdifferentiation from recipient bone marrow to parenchymal cells in regenerating and long-surviving human allografts. Am J Transplant. 2003 Sep; 3(9):1173-81.
Score: 0.004
-
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int. 2003 May; 16(5):336-40.
Score: 0.004
-
Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature. Medicine (Baltimore). 2002 Sep; 81(5):333-48.
Score: 0.004
-
Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002 May 27; 73(10):1598-602.
Score: 0.004
-
Influenza virus infection in adult solid organ transplant recipients. Am J Transplant. 2002 Mar; 2(3):287-91.
Score: 0.004
-
Hemorrhagic complications of enoxaparin and aspirin in patients with kidney transplants. Pharmacotherapy. 2002 Feb; 22(2):184-7.
Score: 0.004
-
Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today. 2002; 32(9):792-9.
Score: 0.004
-
Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence. Transplantation. 2001 Aug 27; 72(4):619-26.
Score: 0.004
-
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Transplant Proc. 2001 Feb-Mar; 33(1-2):1235-6.
Score: 0.003
-
Occult nonhematopoietic malignancies present at autopsy in solid organ transplant patients who died within 100 days. Transplantation. 2001 Jan 15; 71(1):64-9.
Score: 0.003
-
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000 Oct; 191(4):389-94.
Score: 0.003
-
Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J Biol Chem. 2000 Sep 08; 275(36):28083-92.
Score: 0.003
-
Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation. 2000 Aug 15; 70(3):543-5.
Score: 0.003
-
Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation. 2000 Jun 27; 69(12):2566-73.
Score: 0.003
-
Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. Transplantation. 2000 Jun 15; 69(11):2330-6.
Score: 0.003
-
Influence of donor cardiopulmonary arrest in human liver transplantation: possible role of ischemic preconditioning. Hepatology. 2000 Mar; 31(3):577-80.
Score: 0.003
-
Influence of donor condition on postoperative graft survival and function in human liver transplantation. Transplant Proc. 2000 Mar; 32(2):322-6.
Score: 0.003
-
Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol. 2000 Mar; 24(3):375-85.
Score: 0.003
-
Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl. 2000 Mar; 6(2):163-9.
Score: 0.003
-
Late-onset renal failure after liver transplantation: role of posttransplant alcohol use. Transplantation. 2000 Feb 15; 69(3):383-8.
Score: 0.003
-
Prognostic value of abdominal CT scanning and hepatic histopathology in patients with acute liver failure. Dig Dis Sci. 2000 Feb; 45(2):334-9.
Score: 0.003
-
Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 1999 Dec 27; 68(12):1851-4.
Score: 0.003
-
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 1999 Sep; 189(3):291-9.
Score: 0.003
-
Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. Transplant Proc. 1999 Aug; 31(5):2028-31.
Score: 0.003
-
Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999 Jul; 117(1):149-53.
Score: 0.003
-
Effect of t-tube clamping on the pharmacokinetics of mycophenolic acid in liver transplant patients on oral therapy of mycophenolate mofetil. Liver Transpl Surg. 1999 Mar; 5(2):101-6.
Score: 0.003
-
A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999 Feb 15; 67(3):411-5.
Score: 0.003
-
Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management. Transplantation. 1998 Dec 27; 66(12):1596-604.
Score: 0.003
-
A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report. J Urol. 1998 Dec; 160(6 Pt 1):1982-5; discussion 1985-6.
Score: 0.003
-
Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis? Dig Dis Sci. 1998 Nov; 43(11):2459-62.
Score: 0.003
-
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. J Am Coll Surg. 1998 Oct; 187(4):358-64.
Score: 0.003
-
Tacrolimus for rescue of refractory renal allograft rejection. Transplant Proc. 1998 Jun; 30(4):1257-60.
Score: 0.003
-
Induction of CYP2E1 activity in liver transplant patients as measured by chlorzoxazone 6-hydroxylation. Clin Pharmacol Ther. 1998 Mar; 63(3):296-302.
Score: 0.003
-
Orthotopic liver transplantation in high-risk patients: risk factors associated with mortality and infectious morbidity. Transplantation. 1998 Feb 27; 65(4):499-504.
Score: 0.003
-
The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg. 1998 Jan; 4(1):22-7.
Score: 0.003
-
Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997 Nov; 185(5):429-36.
Score: 0.003
-
Cardiac operations in solid-organ transplant recipients. Ann Thorac Surg. 1997 Nov; 64(5):1270-8.
Score: 0.003
-
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation. Hepatology. 1997 Oct; 26(4):877-83.
Score: 0.003
-
The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology. 1997 Aug; 26(2):444-50.
Score: 0.003
-
Non-lymphoid cancer after liver transplantation. Hepatogastroenterology. 1997 Jul-Aug; 44(16):1172-81.
Score: 0.003
-
Tacrolimus rescue therapy for renal allograft rejection--five-year experience. Transplantation. 1997 Jan 27; 63(2):223-8.
Score: 0.003
-
Gastrointestinal bleeding after liver transplantation. Transplantation. 1997 Jan 15; 63(1):60-7.
Score: 0.003
-
Capillary blood versus arterial or venous blood for tacrolimus monitoring in liver transplantation. Transplantation. 1995 Sep 15; 60(5):512-4.
Score: 0.002
-
Immunoglobulin G lymphocytotoxic antibodies in clinical liver transplantation: studies toward further defining their significance. Hepatology. 1995 May; 21(5):1345-52.
Score: 0.002
-
A prospective randomized trial of FK506-based immunosuppression after renal transplantation. Transplantation. 1995 Feb 27; 59(4):485-90.
Score: 0.002
-
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc. 1995 Feb; 27(1):1099-104.
Score: 0.002
-
A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients. Transplant Proc. 1995 Feb; 27(1):814-7.
Score: 0.002
-
Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc. 1995 Feb; 27(1):1184-5.
Score: 0.002
-
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol. 1995 Feb; 19(2):192-206.
Score: 0.002
-
Liver and kidney transplantation from non-heart beating donors: the Pittsburgh experience. Transplant Proc. 1995 Feb; 27(1):710-2.
Score: 0.002
-
Weaning of immunosuppression in long-term liver transplant recipients. Transplantation. 1995 Jan 27; 59(2):212-7.
Score: 0.002
-
Acute pancreatitis after liver transplantation: incidence and contributing factors. Transpl Int. 1995; 8(1):1-7.
Score: 0.002
-
Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation. 1992 May; 53(5):1056-62.
Score: 0.002
-
Human islet allotransplantation under FK 506. Transplant Proc. 1991 Dec; 23(6):3207.
Score: 0.002
-
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation. 1991 Jul; 52(1):71-7.
Score: 0.002
-
Liver transplantation under cyclosporine: a decade of experience. Transplant Proc. 1991 Feb; 23(1 Pt 2):1393-6.
Score: 0.002
-
Liver transplantation in patients over sixty years of age. Transplantation. 1991 Jan; 51(1):271-3.
Score: 0.002
-
The antibody crossmatch in liver transplantation. Surgery. 1986 Oct; 100(4):705-15.
Score: 0.001